Solventum Corporation

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Solventum Corp reports growth amidst challenges, eyes future profitability

Solventum Corporation is navigating challenges while capitalizing on strengths to drive growth.
The company's strategic focus on stabilizing, growing, and optimizing its business bodes well for the future.
Investors should watch for updates on Phase 2 progress and strategic portfolio decisions in the upcoming quarters.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

ST. PAUL, Minn. , April 23, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 2024.

Solventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor Events

ST. PAUL, Minn. , April 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the board.

Solventum Names Shirley Edwards to Board of Directors

The 3M healthcare spinoff picked up two new ratings this week.

Solventum Stock Is Cheap. Why Wall Street Says to Wait.

3M Company has completed the spinoff of its healthcare business, Solventum Corporation, allowing both companies to focus on their respective strengths. Solventum has a well-diversified business model with strong growth opportunities, but faces challenges such as low entry barriers and elevated debt. MMM is showing signs of stability and growth, with settled lawsuits and positive market trends, making it a promising investment with potential for a high total return.

3M Says Bye To Solventum - Why I Stick To My Bullish Call

Solventum (NYSE: SOLV ) stock went live on the New York Stock Exchange today just as its parent company, 3M (NYSE: MMM ), sorted out a recent settlement related to a drinking water agreement. Indeed, on March 29, 3M announced that its prior settlement agreement with U.S. public water suppliers had received final approval in U.S. District Court.

3M Finalizes Drinking Water Settlement Amidst Solventum Spinoff

Healthcare business Solventum (NYSE: SOLV ) — which covers information technology, wound care and other specialties — slipped on its public market debut. SOLV stock represents a spinoff from industrial conglomerate and applied sciences giant 3M (NYSE: MMM ).

Should You Buy Solventum (SOLV) Stock After the 3M Spinoff?

Two big announcements from 3M (MMM) sent shares of the conglomerate higher Monday.

3M Completes Health Care Spinoff, and a Court Finalizes 'Forever Chemicals' Settlement

The spinoff of 3M's healthcare business is complete and shares of the new company, called Solventum, are lower. It could be a buying opportunity.

3M Spinoff Solventum Stock Is Down 16%. What Happens Next.

Solventum Corp (NYSE: SOLV) lost about 3.0% as it debuted on the New York Stock Exchange on Monday. The healthcare name was separated from 3M & Co (NYSE: MMM) in March.

3M healthcare spinoff Solventum slides on NYSE debut

Solventum (NYSE: SOLV ), the healthcare company spun off by 3M (NYSE: MMM ), has started trading independently today on the New York Stock Exchange. Here are seven things investors should know about the spinoff, 3M and it shares, and Solventum and SOLV stock.

SOLV Stock: 7 Things to Know as Solventum Starts Trading Today

Formerly 3M Health Care Business, Solventum (NYSE: SOLV) enables better, smarter, safer healthcare to improve lives ST. PAUL, Minn.

Solventum Begins Trading on the New York Stock Exchange

Fox Factory Hld

General Electric

GE Vernova LLC

ModivCare

E. W. Scripps

V.F.

DENTSPLY SIRONA

NEW YORK , March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE: SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE: VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3.

GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600

Newly minted GE Vernova and Solventum Corp., both soon to be officially spun off from two industrial giants, are hitting it big early: They are joining the S&P 500 index next week.

GE Vernova, Solventum to join S&P 500 index next week

S&P Dow Jones Indices announced changes to its indexes as of the start of the second quarter.

These GE and 3M Spinoffs Are Set to Join the S&P 500

News for Solventum Corporation Stock (SOLV)